Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease

Ming-Cheng Wang1, Wei-Chuan Tsai, Ju-Yi Chen

  • 1Department of Internal Medicine, Division of Nephrology, National Cheng Kung University Medical Center, Tainan, Taiwan, ROC.

Insights

Arterial stiffness, measured by pulse wave velocity (PWV), increases with chronic kidney disease (CKD) progression. Lower estimated glomerular filtration rate (GFR) and higher systolic blood pressure are key factors in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) exhibit high rates of cardiovascular disease (CVD).
  • Premature atherosclerosis and vascular calcification are significant contributors to CVD in CKD patients.
  • Arterial stiffness is a key indicator of cardiovascular risk.

Purpose of the Study:

  • To assess arterial stiffness severity in 102 CKD patients using pulse wave velocity (PWV).
  • To identify risk factors associated with increased arterial stiffness in CKD.

Main Methods:

  • Pulse wave velocity (PWV) was measured by calculating flow wave travel distance divided by time delay.
  • Correlations were analyzed between PWV and cardiovascular risk factors, estimated glomerular filtration rate (GFR), blood pressure (BP), and pulse pressure (PP).

Main Results:

  • PWV was similar in early CKD stages (1-2) and controls but increased significantly with advancing CKD stage.
  • Univariate analysis revealed correlations between PWV and age, prior CVD, diabetes, hypertension, GFR, systolic BP, and PP.
  • Multivariate analysis identified decreased GFR and increased systolic BP as independent predictors of increased PWV in CKD patients.

Conclusions:

  • This study demonstrates a progressive increase in PWV with CKD stages 1-5.
  • Reduced estimated GFR and elevated systolic BP are major determinants of arterial stiffness in CKD.
  • These findings highlight the importance of managing GFR and BP to mitigate arterial stiffness in CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...